United States: At The Federal Circuit

Secondary Considerations: Of Primary Importance in Defending Against an Obviousness Challenge

To determine whether a claim is obvious, the decision-maker must:

  1. determine the scope and content of the prior art;
  2. determine the differences between the prior art and the claim at issue;
  3. assess the level of ordinary skill in the pertinent art; and
  4. evaluate evidence of "secondary considerations" (also known as "objective indicia of nonobvousness"). 

See Graham v. John Deere Co., 383 U.S. 1, 17 (1966). 

A patentee or applicant may rely upon several types of secondary considerations, including teaching away, unexpected results, solving a long-felt but unmet need, acclaim or praise of the claimed invention by others in the field, copying of the claimed features by competitors in the field, and commercial success.  For evidence of secondary considerations to be given weight, there must be a nexus between the evidence and the merits of the claimed invention.  See, e.g., Ashland Oil, Inc. v. Delta Resins & Refractories, Inc., 776 F.2d 281, 306 n.42 (Fed. Cir. 1985).  But secondary considerations, such as unexpected results, do not need to be mentioned in the patent disclosure or recited in the claims.1

In spite of its name and its place as the last of the four Graham factors, "secondary" considerations of nonobviousness can be of primary importance in demonstrating the patentability of a claim.  Such evidence "can establish that 'an invention appearing to have been obvious in light of the prior art was not'" and "may be 'the most probative and cogent evidence in the record.'"  Rambus Inc. v. Rea, 731 F.3d 1248, 1256 (Fed. Cir. 2013) (citations omitted).  The Federal Circuit has emphasized that this evidence guards against the use of hindsight because "[i]t helps 'turn back the clock and place the claims in the context that led to their invention.'"  Id. (citations omitted).  As the Federal Circuit explained in three cases from August and September 2013, the USPTO and other tribunals cannot ignore evidence of secondary considerations offered by a patentee or applicant. 

Apple Inc. v. International Trade Commission, 725 F.3d 1356 (Fed. Cir. 2013), for example, concerned a patent claim covering Apple's transparent, multitouch screen used in the iPhone® and other devices.  The claimed screen is both transparent and able to detect and respond to multiple, simultaneous touches of a user's fingers, unlike prior art screens that were either transparent but not multitouch or multitouch but not transparent.  Id. at 1364-65.  The International Trade Commission (ITC) found Apple's claimed transparent, multitouch screen to be an obvious combination of the multitouch and transparency features described in two items of prior art.  See id.  Apple had offered several types of secondary consideration evidence to support the patentability of its invention, namely, praise from the industry, including news articles describing the claimed screen as "brilliant" and "the most impressive feature of the new iPhone"; evidence that nearly every competitor copied the screen shortly after Apple introduced it; and evidence of commercial success of iPhones including the inventive screen.  Id. at 1366 (citations omitted).  But the ITC did not consider this evidence.  Id.  The Federal Circuit criticized the ITC for not mentioning, let alone weighing, this secondary consideration evidence, and stated that, by failing to consider the evidence, the ITC did not follow precedent and made an error that was "not harmless."  Id. at 1365-66.  The court reiterated that secondary consideration evidence, in fact, "may be 'the most probative and cogent evidence [of patentability] in the record,'" and found that "Apple presented compelling secondary considerations evidence that may have rebutted even a strong showing under the first three Graham factors, and the ITC failed to grapple with it."  Id. at 1366 (alteration in original) (citation omitted).  As a result, the Federal Circuit vacated the ITC's decision and remanded for further consideration.  Id. at 1367.  Judge Reyna, in dissent, argued that the secondary consideration evidence was so strong that the court need not even send the case back to the ITC for further proceedings.  Id. at 1375 (Reyna, J., dissenting).

Rambus v. Rea stemmed from a reexamination proceeding at the USPTO on a patent held by Rambus concerning dynamic random-access memory (DRAM) technology.  Like Apple, Rambus submitted evidence of several types of secondary considerations to the USPTO, including satisfaction of a long-felt but unmet need, industry praise, and commercial success.  The Federal Circuit held that the USPTO had not properly considered this evidence in concluding that the claims were obvious.  For example, the court found that the USPTO did not address evidence of industry praise, including a press release by a competitor calling Rambus's invention "revolutionary and pioneering technology."  Rambus 731 F.3d at 1256-57 (citation omitted).  The court also found that the USPTO erred in concluding there was a lack of nexus between the evidence and the claimed invention, applying too strict a standard in judging nexus.  Id.  The court pointed out that "[o]bjective evidence of non-obviousness need only be 'reasonably commensurate with the scope of the claims.'"  Id. (emphasis added) (citation omitted).  Accordingly, as in Apple, the court vacated the USPTO decision and remanded for reconsideration.

The final case in this trio, Leo Pharm. Prods., Ltd. v. Rea, 726 F.3d 1346 (Fed. Cir. 2013), also an appeal from a USPTO reexamination, emphasizes that secondary consideration evidence can be crucial in defending claimed inventions that, on their face, appear to encompass only small changes from the prior art or appear to be simple combinations of known elements.  That case concerned a pharmaceutical formulation that appeared to be a simple mixture of three ingredients—two active agents and a solvent.  The claim also recited the result-oriented limitation that the formulation is "storage stable."  Id. at 1349-50.  The USPTO found the claims invalid over a combination of three references, two reciting prior compositions comprising mixtures of the two active agents, and the third disclosing the claimed solvent.  Id. at 1350-51.  The Federal Circuit reversed, noting that, while formulations containing both active agents had been made previously, Leo Pharmaceuticals had provided evidence to the USPTO that those prior formulations would not have been able to remain stable in storage because the two active ingredients require different and incompatible conditions, and that this storage stability problem was not recognized in the prior art.  Id. at 1354-55.  During proceedings before the USPTO, Leo Pharmaceuticals had also provided evidence of unexpected results, teaching away, and commercial success.  Id. at 1353-54, 1358.  The court agreed with Leo Pharmaceuticals that the three cited references taught away from the claimed invention, and found its evidence of secondary considerations compelling.  Id. at 1355-56.  The court also noted that, while it had been known for a long time that using the two claimed active agents together was beneficial, the evidence suggested that Leo Pharmaceuticals was the first to develop a formulation comprising both active agents that was storage stable.  See generally id. at 1358-59.  The decision pointed out that "[t]he length of the intervening time between the publication dates of the prior art and the claimed invention can also qualify as an objective indicator of nonobviousness," and that the fourteen- to twenty-two-year gap in this case "speaks volumes to the nonobviousness of the . . . patent."  Id. at 1359.

These three cases highlight that bodies such as the USPTO and ITC are required to consider and weigh evidence of secondary considerations when presented by an applicant or patentee, and that such evidence can in some cases be the best evidence of patentability.  Accordingly, patent applicants, for example, should ensure that the examiner has properly considered secondary consideration evidence, and should consider bringing these cases to the examiner's attention, if not.  Applicants or patent holders defending claims that, on their face, may appear to be noninventive should be prepared to provide secondary consideration evidence to the USPTO or other tribunal as, in such cases, it might well be the best evidence to support patentability.

Footnote

1 Although reciting unexpected results expressly in the claims can be helpful in withstanding a validity challenge, as noted in another article in this issue of Full DisclosureSee also Galderma Labs., L.P. v. Tolmar, Inc., 737 F.3d 731 (Fed. Cir. 2013).

This article previously appeared in Full Disclosure Patent Prosecution Update, January 2014.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Events from this Firm
27 Nov 2017, Seminar, London, UK

Finnegan partner Anthony Tridico will present “U.S. Patent Case Law Update” at the Chartered Institute of Patent Attorneys’ annual Patent Case Law Review.

28 Nov 2017, Seminar, Milan, Italy

Finnegan partner John Paul will present “Internet of Things: Patent Liability, Enforcement and Licensing” and will join the Mock WIPO Mediation at International Technology Transfer—Licensing and ADR, co-hosted by Licensing Executives Society and World Intellectual Property Organization.

29 Nov 2017, Seminar, Tel Aviv, Israel

Finnegan is a platinum sponsor IVC Research Center’s start-up forum, “The Most Promising Start Ups for 2017 – A Synergy of Big Data, Artificial Intelligence, Machine Vision and IoT.”

 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Emails

From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.